Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 14 studies | 22% ± 3% | |
dendritic cell | 8 studies | 46% ± 13% | |
CD4-positive, alpha-beta T cell | 6 studies | 19% ± 4% | |
T follicular helper cell | 5 studies | 17% ± 2% | |
CD8-positive, alpha-beta T cell | 5 studies | 20% ± 5% | |
conventional dendritic cell | 3 studies | 19% ± 1% | |
monocyte-derived dendritic cell | 3 studies | 36% ± 16% |
Insufficient scRNA-seq data for expression of TRAF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2885.41 | 653 / 653 | 99% | 14.05 | 601 / 605 |
lung | 100% | 2698.00 | 577 / 578 | 97% | 14.78 | 1125 / 1155 |
intestine | 99% | 2405.36 | 959 / 966 | 95% | 9.13 | 502 / 527 |
esophagus | 99% | 2412.90 | 1437 / 1445 | 95% | 11.58 | 174 / 183 |
breast | 100% | 2095.54 | 458 / 459 | 94% | 12.15 | 1055 / 1118 |
stomach | 98% | 1871.26 | 351 / 359 | 96% | 10.25 | 275 / 286 |
uterus | 100% | 2559.81 | 170 / 170 | 93% | 11.25 | 429 / 459 |
prostate | 100% | 3586.27 | 245 / 245 | 93% | 7.39 | 468 / 502 |
kidney | 100% | 2219.56 | 89 / 89 | 92% | 14.49 | 827 / 901 |
skin | 95% | 1543.77 | 1723 / 1809 | 96% | 51.39 | 452 / 472 |
adrenal gland | 98% | 2674.89 | 254 / 258 | 91% | 9.23 | 209 / 230 |
bladder | 100% | 2754.62 | 21 / 21 | 89% | 10.42 | 449 / 504 |
brain | 96% | 1187.83 | 2530 / 2642 | 89% | 9.96 | 630 / 705 |
pancreas | 76% | 674.19 | 248 / 328 | 98% | 13.17 | 174 / 178 |
ovary | 100% | 3143.25 | 180 / 180 | 73% | 4.74 | 312 / 430 |
liver | 85% | 857.27 | 191 / 226 | 76% | 6.39 | 307 / 406 |
blood vessel | 100% | 4577.01 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 164.16 | 29 / 29 |
spleen | 100% | 3531.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.01 | 45 / 45 |
adipose | 99% | 2036.36 | 1197 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6723.45 | 907 / 929 | 0% | 0 | 0 / 0 |
heart | 81% | 1113.10 | 696 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 6.91 | 64 / 80 |
muscle | 34% | 251.60 | 275 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_2001236 | Biological process | regulation of extrinsic apoptotic signaling pathway |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0098802 | Cellular component | plasma membrane signaling receptor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005164 | Molecular function | tumor necrosis factor receptor binding |
GO_0031996 | Molecular function | thioesterase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TRAF1 |
Protein name | TNF receptor associated factor 1/ALK receptor tyrosine kinase fusion protein TNF receptor-associated factor 1 (Epstein-Barr virus-induced protein 6) |
Synonyms | fusion ALK EBI6 |
Description | FUNCTION: Adapter molecule that regulates the activation of NF-kappa-B and JNK. Plays a role in the regulation of cell survival and apoptosis. The heterotrimer formed by TRAF1 and TRAF2 is part of a E3 ubiquitin-protein ligase complex that promotes ubiquitination of target proteins, such as MAP3K14. The TRAF1/TRAF2 complex recruits the antiapoptotic E3 protein-ubiquitin ligases BIRC2 and BIRC3 to TNFRSF1B/TNFR2. . |
Accessions | ENST00000373887.8 [Q13077-1] ENST00000540010.1 [Q13077-1] Q13077 ENST00000546084.5 [Q13077-2] A0A6G8IRL2 |